Zhengye Biotechnology Holding Limited
ZYBT
Get informed when a big investor buys or sells
+ FollowMarket Cap$39.34M
Close$
$0.48
41.7% downside
Current Fair Value
41.7% downsideOvervalued by 41.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $39.34 Million |
|---|---|
| Enterprise Value | $71.27 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0 |
| Beta | -2.39 |
| Outstanding Shares | - |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | 0 |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | 1.15 |
| Debt to Equity | 0.33 |
Revenue Sources
No data
Insider Trades
Institutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.26%▼ 0.23% |
|---|---|
| Total Invested | $113,003▼ 57.33% |
| Investors Holding | 8▼ 2.00% |
ESG Score
No data
About Zhengye Biotechnology Holding Limited
278 employees
CEO: Songlin Song Zhengye Biotechnology Holding Limited engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in China. It offers vaccines for swine, cattle, goats, sheep, poultry, and dogs. The company also expo...